http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1077959-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae43044eedb639ebdeffc4561d0d3cf5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate | 1999-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a51db215cc96b21be3a5a4c7a7e4e10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b47f29fd4f6ce19ac0012acdf150f09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d9d6e5ecfe8f77d72481dad3b1552b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_317fbcba93c7c41ffd92a1e17e3d14e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc80ae33c018acd4056d8b798f64634e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e8c1a4b37a2a732eb11ac6d9281fb8 |
| publicationDate | 2001-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1077959-A1 |
| titleOfInvention | Morpholino ethers |
| abstract | A morpholino ether (I), and physiologically acceptable salts and or metabolically labile derivatives thereof, wherein R1 represents C¿1-6? straight or branched chain alkyl, C1-6 straight or branched chain alkoxy, optionally substituted phenoxy, C3-6 straight or branched chain alkenyloxy (optionally substituted by 1 or 2 halogen atoms) or C1-4 straight or branched alkoxy substituted by an optionally substituted phenyl group, C3-8 straight or branched chain alkynyl, C3-6 straight or branched chain alkenyl (optionally substituted by C1-4 alkoxy or 1 or 2 halogen atoms), optionally substituted phenyl, optionally substituted C3-7 cycloalkyl, optionally substituted C5-7 cycloalkenyl, C2-4 straight or branched chain alkyl substituted by (C1-4 alkoxy, C1-4 alkyl thio or halogen), C1-4 straight or branched chain alkyl substituted by (C1-4 alkoxycarbonyl, arylalkyloxycarbonyl, aryloxycarbonyl, propadienyl, cyano, optionally substituted C3-7 cycloalkyl, optionally substituted 5 or 6 membered heteroaryl, or 1 or 2 optionally substituted phenyl groups), or methyl substituted by C1-6 alkanoyl or optionally substituted benzoyl; R2 represents a group selected from hydrogen, C1-6 straight or branched chain alkyl, C3-6 straight or branched chain alkenyl, optionally substituted phenyl or C1-4 alkyl substituted with a group selected from C1-4 alkoxy, hydroxy, acyloxy, alkoxy carbonyl or aryloxycarbonyl, and R3 represents a group selected from formyl or cyano; processes for their preparation, their use in medicine and intermediates for their preparation. |
| priorityDate | 1998-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 534.